USAQ (QHSLab) Notes Receivable: $0.00 Mil (As of Mar. 2026)


USAQ QHSLab Inc USAQ
47 GF Score
Price $0.27
GF Value $0.19
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is QHSLab Notes Receivable?

QHSLab USAQ 47 Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus rates USAQ with a GF Score™ of 47/100 and a GF Value™ of $0.19 (Significantly Overvalued). The stock has 3 warning signs investors should review.

QHSLab's Notes Receivable for the quarter that ended in Mar. 2026 was $0.00 Mil.

QHSLab Notes Receivable Historical Data

* Premium members only.

The historical data trend for QHSLab's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QHSLab Notes Receivable Chart

QHSLab Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

QHSLab Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
USAQ
47GF Score
QHSLab Inc USAQ
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

QHSLab Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
QHSLab (USAQ) has a Notes Receivable of $0.00 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on QHSLab and its competitors.
Is QHSLab's Notes Receivable too high?
QHSLab's current Notes Receivable is $0.00 Mil. Overall, QHSLab has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does QHSLab's Notes Receivable compare to ADMT and RMSL?
QHSLab's Notes Receivable of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on QHSLab and its competitors. QHSLab's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QHSLab stock overvalued right now?
Based on GuruFocus' analysis, QHSLab (USAQ) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.19, compared to a current price of $0.27 — trading 39.5% above its estimated fair value. The current Notes Receivable is $0.00 Mil. QHSLab's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For QHSLab (USAQ), the current Notes Receivable is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is QHSLab (USAQ) Overvalued in 2026?

Based on GuruFocus' analysis, QHSLab stock appears to be overvalued. The current stock price of $0.27 is trading 39.5% above its estimated GF Value™ of $0.19. GuruFocus considers QHSLab to be Significantly Overvalued.

Key valuation signals for USAQ:

  • Notes Receivable: $0.00 Mil
  • GF Value™: $0.19 vs. price of $0.27 (39.5% above fair value)
  • GF Score™: 47/100 with 3 warning signs

No single metric tells the full story. See the USAQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

QHSLab Business Description

Address 901 Northpoint Parkway, Suite 302, West Palm Beach, FL, USA, 33407
QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. The company is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.
47GF Score

Get the complete analysis for USAQ

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.27
Price
$0.19
GF Value